Xtx Topco LTD Black Diamond Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $710 Million
- Q1 2024
A detailed history of Xtx Topco LTD transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 12,416 shares of BDTX stock, worth $63,694. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,416Holding current value
$63,694% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding BDTX
# of Institutions
93Shares Held
36.5MCall Options Held
29.6KPut Options Held
5K-
Bellevue Group Ag Kuesnacht, V88.52MShares$43.7 Million0.68% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$34.5 Million0.02% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$22.8 Million1.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.91MShares$9.77 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.6MShares$8.22 Million0.99% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $186M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...